PeDRA

Pediatric Dermatology Research Alliance

Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children

By

Moderate-to-severe atopic dermatitis is associated with negative impacts on quality of life and health outcomes in all age groups, with the impact on children and families being uniquely severe. However, the rapid pace of drug development and uncertainty around novel medications may impact the shared decision-making process and lead to suboptimal treatment of many children. Thus, educating pediatric dermatologists and allergists is critical to positively affect treatment decisions and improve long-term outcomes. In addition, engaging experts in pediatric dermatology and allergy to consider what are the most important research issues in atopic dermatitis is important to direct future efforts. To address this need and help fill the gap left by canceled conferences in 2020, PeDRA is conducting a six-part educational series Emerging Therapies for Moderate-to-Severe Atopic Dermatitis in Children.      

Being hosted by distinguished faculty in pediatric dermatology and allergy/immunology, this non-CME program will include a total of six parts, including two webinars, two podcasts, and two virtual meetings/townhalls. 

Part 1: PEDIATRIC ATOPIC DERMATITIS – New and Emerging Systemic Therapies: An Overview
RECORDED LIVE: Tuesday, October 6, 5:15 – 6:15PM PDT / 8:15 – 9:15PM EDT

Chair: Lawrence Eichenfield, MD
Speakers: Megha Tollefson, MD and Bob Geng, MD
Panel: Wynnis Tom, MD and Dawn Davis, MD

View Full Agenda

5:15 – 5:20 – Introduction
5:20 – 5:37 – Biologics – Overview and translation to practice
5:37 – 5:49 – JAK-inhibitors
5:49 – 6:01 – Mechanisms of action and allergy perspectives
6:01 – 6:15 – Moderated discussion with audience

Watch NOW

Part 2: PEDIATRIC ATOPIC DERMATITIS – Algorithms of the Future
Tuesday, October 13, 5:15 – 6:15PM PDT / 8:15 – 9:15PM EDT

Chair: Lawrence Eichenfield, MD
Speakers: Dawn Davis, MD and Wynnis Tom, MD
Panel: Megha Tollefson, MD and Bob Geng, MD

View Full Agenda

5:15 – 5:20 – Introduction
5:20 – 5:32 – New topicals for moderate to severe disease
5:32 – 5:42 – New and traditional systemics: where do they fit?
5:42 – 6:00 – Considerations when selecting appropriate therapy for the appropriate patient
6:00 – 6:15 – Interactive discussion on “hot” research issues in moderate to severe atopic dermatitis for pediatric dermatologists and allergists

Watch now

Part 3: TBA

Join us for the first of two podcasts in November 2020 for a conversation with faculty. More information coming soon.

Part 4: TBA

Your chance to ask questions and interact with the faculty from the first podcast.

Part 5: TBA

Listen to the second of two podcasts in December 2020 for a conversation with faculty and patients and parents living with moderate-to-severe atopic dermatitis. More information coming soon.

Part 6: TBA

Your chance to ask questions and interact with faculty, patients, and parents from the second podcast.

FACULTY

Lawrence Eichenfield, MD

Chair

Professor of Dermatology and Pediatrics
Chief, Pediatric and Adolescent Dermatology
Vice Chair, Department of Dermatology
University of California, San Diego and Rady Children’s Hospital, San Diego

    Bob Geng, MD

    Assistant Professor of Medicine and Pediatrics
    Divisions of Adult and Pediatric Allergy & Immunology
    Co-Director of the Allergy Asthma Foundation of America sponsored UCSD Pediatric Severe Asthma Program
    Allergy/Immunology Director of the Multidisciplinary Atopic Dermatitis Program
    University of California, San Diego and Rady Children’s Hospital, San Diego

      Dawn Davis, MD

      Professor of Dermatology and Pediatrics
      Division Chair, Clinical Dermatology
      Director, Section of Pediatric Dermatology
      Mayo Clinic Rochester

        Megha Tollefson, MD

        Associate Professor of Dermatology and Pediatrics
        Consultant, Dermatology
        Consultant, Pediatric and Adolescent Medicine
        Mayo Clinic Rochester

          Wynnis Tom, MD

          Clinical Professor of Dermatology and Pediatrics
          Fellowship Program Director
          Pediatric & Adolescent Dermatology
          University of California, San Diego and Rady Children’s Hospital, San Diego

            Special thanks to Pfizer Inc. for their support of this independent medical education program.  PeDRA is solely responsible for all program content and the selection of all presenters, authors, moderators, and faculty.